Advisor Group Holdings, Inc. Edesa Biotech, Inc. Transaction History

Advisor Group Holdings, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$0.77 - $1.16 $3 - $4	4 Added 100.0%	8 $0
Q1 2023 May 12, 2023	SELL	$0.91 - $2.63 $91 - $263	-100 Reduced 96.15%	4 $0
Q4 2022 Feb 10, 2023	SELL	$0.8 - $8.05 $3 - $32	-4 Reduced 3.7%	104 $0
Q3 2022 Nov 14, 2022	BUY	$1.39 - $9.94 $5 - $39	4 Added 3.85%	108 $0
Q1 2021 May 13, 2021	SELL	$4.3 - $7.48 $4 - $7	-1 Reduced 0.95%	104 $1,000
Q4 2020 Feb 10, 2021	SELL	$4.25 - $8.14 $114 - $219	-27 Reduced 20.45%	105 $0
Q2 2020 Aug 14, 2020	SELL	$2.0 - $6.62 $14 - $46	-7 Reduced 5.04%	132 $1,000
Q1 2020 May 18, 2020	BUY	$1.64 - $4.09 $227 - $568	139 New	139 $0

Ticker EDSA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 15,462,300
Market Cap $38.2M
Description
Edesa Biotech, Inc., a biopharmaceutical company, engages in acquiring, developing, and commercializing clinical-stage drugs for inflammatory and immune-related diseases with clear unmet medical needs. Its lead product candidates are EB05, a monoclonal antibody, which is in Phase 3 clinical study for the treatment of acute respiratory distress s...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.